Many also contained high doses of vitamins and minerals, occasionally more than the tolerable limit
semaglutide itself can occasionally cause tachycardia or palpitations in sensitive individuals
The starting dose of semaglutide was 0.25 mg/week for 2 weeks, followed by 0.5 mg/week for 2 weeks, escalating to 1.0 mg/week for 12 weeks
Similarly, empagliflozin suppresses NLRP3 inflammasome activation in macrophages of diabetic patients (Kim et al., 2020)
In addition to dietary and pharmaceutical influences, new research confirms that GLP-1 secretion is impacted by sex as well as many personal health factors, including glucose tolerance and overall metabolic health, body weight, microbiome composition, and even eating behaviour itself (Huber et al., 2024)